Definitions and general remarks on surgical pathology in the field of oncology;Volume tumoral macroscopique et volume-cible anatomoclinique en radiothérapie: Généralités. Définitions et généralités en anatomie pathologique

Cancer/Radiotherapie

Volumn 5, Issue 5, 2001, Pages 488-495

  Arnould, L ^a  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

Definition; Description; Oncology; Prognosis; Surgical pathology; Tumour

Indexed keywords

ARTICLE; BASEMENT MEMBRANE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; HUMAN; MICROSCOPY; ONCOLOGY; PATHOLOGICAL ANATOMY; PATHOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; STROMA;

EID: 0034783599     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(01)00092-0     Document Type: Short Survey

References (43)

1. Standards, Options and Recommendations (SOR) for drafting of anatomic and surgical pathology reports or cytopathology reports in oncology
2. Recommendations for the reporting of resected prostate carcinomas
3. Recommendations for the reporting of resected esophageal carcinomas
4. Recommendations for the reporting of urinary bladder specimens containing bladder neoplasms
5. Recommendations for anatamopathologic management of soft tissue sarcomas in the adult
6. Protocol for the examination of specimens removed from patients with gastric carcinoma: A basis for checklists
7. Protocol for the examination of specimens from patients with Hodgkin's disease: A basis for checklists
8. Protocol for the examination of specimens from patients with non-Hodgkin's lymphoma: A basis for checklists
9. Protocol for the examination of specimens from patients with endocrine tumors of the pancreas, including those with mixed endocrine and acinar cell differentiation: A basis for checklists
10. Protocol for the examination of specimens from patients with carcinoma of the ampulla of Vater: A basis for checklists
11. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: A basis for checklists
12. Updated protocol for the examination of specimens from patients with carcinomas of the breast
13. Protocol for the examination of specimens from patients with carcinomas of the extrahepatic bile ducts, exclusive of sarcomas and carcinoid tumors: A basis forchecklists
14. Protocol for the examination of specimens from patients with carcinomas of the gallbladder, including those showing focal endocrine differentiation: A basis for checklists
15. Protocol for the examination of specimens from patients with carcinomas of the cervix: A basis for checklists
16. Protocol for the examination of specimens removed from patients with carcinomas of the upper aerodigestive tract: Carcinomas of the oral cavity including lip and tongue, nasal and paranasal sinuses, pharynx, larynx, salivary glands, hypopharynx, oropharynx, and nasopharynx
17. Practice protocol for the examination of specimens from patients with lung cancer
18. Protocol for the examination of specimens from patients with carcinomas of the anus and anal canal: A basis for checklists
19. Protocol for the examination of specimens from patients with carcinoma of the vagina: A basis for checklists
20. Protocol for the examination of specimens from patients with carcinomas of the endometrium: A basis for checklists
21. Protocol for the examination of specimens from patients with carcinomas and malignant melanomas of the vulva: A basis for checklists
22. Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate
23. Prognostic factors in breast cancer
24. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
25. European recommendations for quality assurance in the setting of mammographic screening for breast cancer
26. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: A determinant of outcome
27. Prognostic factors in carcinoma of the vulva: A clinicopathologic and DNA flowcytometric study
28. Preoperative radiotherapy and surgery for endometrial carcinoma: Prognostic significance of the sterilization of the specimen
29. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva
30. Lymph node staging standards in gastric cancer
31. Comparison of Lauren's, Ming's and WHO histological classifications of gastric cancer as a prognostic factor for operated patients
32. Prognostic factors in colorectal cancer
33. Pathology report in colon cancer: What is prognostically important?
34. Malignant tumors in the head of the pancreas and the periampullary region. Diagnostic and prognostic aspects
35. Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates
36. Prognostic value of histopathologic parameters of esophageal squamous cell carcinoma
37. The prognostic importance of peritoneal involvement in colonic cancer: A prospective evaluation
38. Blood vessel and lymphatic vessel invasion in resected non small cell lung carcinoma. Correlation with TNM stage and disease free and overall survival
39. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues
40. Intravesical adipose tissue: A quantitative study of its presence and location with implications for therapy and prognosis
41. Microstaging of pT1 transitional cell carcinoma of the bladder: Identification of subgroups with distinct risks of progression
42. Rôle du pathologiste dans le traitement de l'ostéosarcome
43. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor